QCM
AZN icon

Quest Capital Management’s AstraZeneca AZN Stock Holding History

Quest Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$320K Hold
2,745
– – 0.06% 231
2021
Q3 		$330K Buy
2,745
+284
+12% +$33.1K 0.06% 201
2021
Q2 		$295K Buy
2,461
+142
+6% +$15.6K 0.06% 217
2021
Q1 		$231K Buy
+2,319
New +$233K 0.05% 234

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Quest Capital Management's AZN Position: Q4 2021 in Review

Quest Capital Management held its AstraZeneca (AZN) position steady in Q4 2021 at 2,745 shares worth $320K. The position accounts for 0.06% of the portfolio, ranked #231.

Quest Capital Management first reported a position in AZN in Q1 2021 and has held it in 4 quarters since. The position peaked at $330K in Q3 2021. 949 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

  • Quest Capital Management held 2,745 shares of AstraZeneca worth $320K as of Q4 2021.
  • Quest Capital Management left its AstraZeneca share count unchanged in Q4 2021.
  • AstraZeneca made up 0.06% of Quest Capital Management's portfolio in Q4 2021, its #231 holding.
  • Quest Capital Management first reported a position in AstraZeneca in Q1 2021 and has held it in 4 quarters since.
  • Quest Capital Management's AstraZeneca position peaked at $330K in Q3 2021.
  • 949 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on Quest Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.